184 related articles for article (PubMed ID: 34068119)
21. Use of In Vivo Imaging System Technology in Leishmania major BALB/c Mouse Ear Infection Studies.
Cawlfield A; Vesely B; Ngundam F; Butler K; Nugent D; Rowland T; Caridha D
J Med Entomol; 2018 Feb; 55(2):429-435. PubMed ID: 29253231
[TBL] [Abstract][Full Text] [Related]
22. Combination of Subtherapeutic Doses of Tretazicar and Liposomal Amphotericin B Suppresses and Cures
Caridha D; Sciotti RJ; Sousa J; Vesely B; Teshome T; Bonkoungou G; Vuong C; Leed S; Khraiwesh M; Penn E; Kreishman-Deitrick M; Lee P; Pybus B; Lazo JS; Sharlow ER
ACS Infect Dis; 2021 Feb; 7(2):506-517. PubMed ID: 33529014
[TBL] [Abstract][Full Text] [Related]
23. EAPB0503: An Imiquimod analog with potent in vitro activity against cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica.
El Hajj R; Bou Youness H; Lachaud L; Bastien P; Masquefa C; Bonnet PA; El Hajj H; Khalifeh I
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006854. PubMed ID: 30462645
[TBL] [Abstract][Full Text] [Related]
24. Label-Free Proteomic Analysis Reveals Parasite-Specific Protein Alterations in Macrophages Following Leishmania amazonensis, Leishmania major, or Leishmania infantum Infection.
Negrão F; Fernandez-Costa C; Zorgi N; Giorgio S; Nogueira Eberlin M; Yates JR
ACS Infect Dis; 2019 Jun; 5(6):851-862. PubMed ID: 30978002
[TBL] [Abstract][Full Text] [Related]
25. Morinda citrifolia Linn. Reduces Parasite Load and Modulates Cytokines and Extracellular Matrix Proteins in C57BL/6 Mice Infected with Leishmania (Leishmania) amazonensis.
Almeida-Souza F; Cardoso Fde O; Souza BV; do Valle TZ; de Sá JC; Oliveira Idos S; de Souza Cda S; Moragas Tellis CJ; Chagas Mdo S; Behrens MD; Abreu-Silva AL; Calabrese Kda S
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004900. PubMed ID: 27579922
[TBL] [Abstract][Full Text] [Related]
26. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
[TBL] [Abstract][Full Text] [Related]
27. Genomic insights into virulence mechanisms of Leishmania donovani: evidence from an atypical strain.
Samarasinghe SR; Samaranayake N; Kariyawasam UL; Siriwardana YD; Imamura H; Karunaweera ND
BMC Genomics; 2018 Nov; 19(1):843. PubMed ID: 30486770
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the Potential of Ursolic Acid as Bioproduct for Cutaneous and Visceral Leishmaniasis.
Bilbao-Ramos P; Serrano DR; Ruiz Saldaña HK; Torrado JJ; Bolás-Fernández F; Dea-Ayuela MA
Molecules; 2020 Mar; 25(6):. PubMed ID: 32204358
[TBL] [Abstract][Full Text] [Related]
29. Application of Quantitative PCR in the Diagnosis and Evaluating Treatment Efficacy of Leishmaniasis.
Wu Y; Tian X; Song N; Huang M; Wu Z; Li S; Waterfield NR; Zhan B; Wang L; Yang G
Front Cell Infect Microbiol; 2020; 10():581639. PubMed ID: 33117735
[TBL] [Abstract][Full Text] [Related]
30. Leishmaniasis in Turkey: Visceral and cutaneous leishmaniasis caused by Leishmania donovani in Turkey.
Özbilgin A; Harman M; Karakuş M; Bart A; Töz S; Kurt Ö; Çavuş İ; Polat E; Gündüz C; Van Gool T; Özbel Y
Acta Trop; 2017 Sep; 173():90-96. PubMed ID: 28587839
[TBL] [Abstract][Full Text] [Related]
31. Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis.
Eissa MM; Amer EI; El Sawy SM
Exp Parasitol; 2011 Aug; 128(4):382-90. PubMed ID: 21620834
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis.
Ware JM; O'Connell EM; Brown T; Wetzler L; Talaat KR; Nutman TB; Nash TE
Clin Infect Dis; 2021 Oct; 73(7):e2457-e2562. PubMed ID: 33124666
[TBL] [Abstract][Full Text] [Related]
33. Clinical and immunological spectra of human cutaneous leishmaniasis in North Africa and French Guiana.
Saidi N; Blaizot R; Prévot G; Aoun K; Demar M; Cazenave PA; Bouratbine A; Pied S
Front Immunol; 2023; 14():1134020. PubMed ID: 37575260
[TBL] [Abstract][Full Text] [Related]
34. Cutaneous Leishmaniasis in the Metropolitan City of Multan, Pakistan, a Neglected Tropical Disease.
Ayaz MM; Nazir MM; Ullah N; Zaman A; Akbar A; Zeeshan M; Hussain Z; Naz S; Zheng Y; Javed A; Lindsay DS
J Med Entomol; 2018 Jun; 55(4):1040-1042. PubMed ID: 29415246
[TBL] [Abstract][Full Text] [Related]
35. [Cutaneous Leishmaniasis Cases Caused by Leishmania infantum in Şanlıurfa Province, Turkey].
Yıldız Zeyrek F; Töz S; Uluca N; Doni N; Toprak Ş; Özbel Y
Mikrobiyol Bul; 2020 Oct; 54(4):647-656. PubMed ID: 33107294
[TBL] [Abstract][Full Text] [Related]
36. Immunological characteristics of experimental murine infection with Leishmania (Leishmania) amazonensis.
Pereira BA; Alves CR
Vet Parasitol; 2008 Dec; 158(4):239-55. PubMed ID: 18922635
[TBL] [Abstract][Full Text] [Related]
37. Molecular Identification of
Behravan M; Moin-Vaziri V; Haghighi A; Rahbarian N; Taghipour N; Abadi A; Hajjaran H
J Arthropod Borne Dis; 2017 Mar; 11(1):124-131. PubMed ID: 29026859
[TBL] [Abstract][Full Text] [Related]
38. Cryotherapy of cutaneous leishmaniasis caused by
Shaddel M; Sharifi I; Karvar M; Keyhani A; Baziar Z
J Vector Borne Dis; 2018; 55(1):42-46. PubMed ID: 29916447
[TBL] [Abstract][Full Text] [Related]
39. Recombinant Cysteine Proteinase B from Leishmania braziliensis and Its Domains: Promising Antigens for Serodiagnosis of Cutaneous and Visceral Leishmaniasis in Dogs.
Bivona AE; Czentner L; Sanchez Alberti A; Cerny N; Cardoso Landaburu AC; Nevot C; Estévez O; Marco JD; Basombrio MA; Malchiodi EL; Cazorla SI
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434727
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
